Interactive decision trainers for 61 cancer types — rehearse real oncology decisions on synthetic patients, with every recommendation traced to a primary source, graded honestly, and stamped with an expiry date. One versioned JSON spec per condition; every app, scenario deck, and credibility file is a build product regenerated from it and gated by conformance tests before release.
flagship
gate ✓ 10 props Blood & marrowmixture-cure family · v1.4 upgrade
gate ✓ 12 props Blood & marrowfirst two-developer-era run
gate ✓ 12 props Blood & marrowthe KMT2A biology · the blinatumomab turn
gate ✓ 14 props Blood & marrowfirst factory-built
gate ✓ 10 props Blood & marrowthe split the aml run opened
gate ✓ 13 props Blood & marrowwatch-and-wait modeled as a ranked arm
gate ✓ 12 props Blood & marrowborn with the care-delivery layer
gate ✓ 11 props Blood & marrowthe five-day cure, kept honest
gate ✓ 11 props Blood & marrowtwo goals, one honest scoreboard · the VERONA lesson
gate ✓ 14 props Blood & marrowthe JAK era · the count-control discipline
gate ✓ 13 props Blood & marrowthe MDS/MPN overlap · the post-HMA cliff
gate ✓ 14 props Blood & marrowthe marathon · ranked only on what has finished aging
gate ✓ 13 props Blood & marrowthe two-currency disease · the anti-fibril frontier
gate ✓ 13 props Lymphomathe scan that removes a drug · Deauville checkpoint
gate ✓ 11 props Lymphomathe renamed entity · the transformation watch
gate ✓ 14 props Lymphomathe 12-month line · three trials, one question, two answers
gate ✓ 14 props Lymphomathe double-hit entity · FISH decides; no trial ever proved the intensity
gate ✓ 12 props Lymphomathe young-mediastinal entity · the radiation-sparing turn
gate ✓ 14 props Lymphomathe scoreboard is burden, not survival · the confirmatory-evidence ledger
gate ✓ 14 props Lymphomathe skin-limited entity · the over-treatment lesson
gate ✓ 12 props Lymphomatwo currencies: survival and cognition · the steroid trap
gate ✓ 12 props Breastthe operation is also a readout · pCR-adaptive therapy
gate ✓ 13 props Breastthe clinical-diagnosis emergency · trimodality non-negotiable
gate ✓ 12 props Breastgoals change, honesty doesn't · the HER2-low rewrite
gate ✓ 12 props Breastrecurrence is not survival · the watching frontier
gate ✓ 10 props Lung & thoraxthe ticket rack · ten drivers, one panel
gate ✓ 12 props Lung & thoraxthe anti-ticket-rack · tempo is the biology
gate ✓ 11 props GIthe ctDNA frontier · organ preservation earned
gate ✓ 12 props GIthe resectability fork · the pan-RAS turn
gate ✓ 12 props GUthe risk ladder · the intensification era
gate ✓ 13 props GUthe intravesical era · the EV+P rewrite
gate ✓ 13 props GUthe doublet era · the adjuvant honesty ledger
gate ✓ 13 props Skinthe immunotherapy flagship · the neoadjuvant turn
gate ✓ 13 props Skinthe commonest cancer · the rarest killer
gate ✓ 12 props Skinthe dangerous sibling · the transplant multiplier
gate ✓ 14 props Skinthe virus-made skin cancer · the IO-first chapter
gate ✓ 14 props Gynecologicthe PARP maintenance era · the HRD fork
gate ✓ 13 props Gynecologicthe molecular reclassification · the dMMR-IO era
gate ✓ 13 props Gynecologicthe accidental diagnosis · histology is the disease
gate ✓ 12 props Gynecologicthe preventable disease · the chemoradiation-IO turn
gate ✓ 13 props Head, neck & endocrinethe HPV fork · the de-escalation frontier
gate ✓ 14 props Head, neck & endocrinethe good-prognosis trap · watching earned its trial
gate ✓ 13 props GIthe trimodality standard · the adjuvant-IO turn
gate ✓ 15 props GIthe perioperative backbone · the biomarker quartet
gate ✓ 15 props GIthe two-disease problem · the IO-doublet era
gate ✓ 14 props GIthe anatomy-split family · the actionable-alteration surprise
gate ✓ 13 props GIthe surgery-sparing original · the HPV receipt
gate ✓ 14 props GIthe incidental diagnosis · grade is destiny
gate ✓ 12 props GUthe curable archetype · surveillance is a spine
gate ✓ 13 props Bone & soft tissueseventy diseases in a trench coat · histology routes everything
gate ✓ 12 props GIthe targeted-therapy original · genotype is the dose
gate ✓ 12 props Bone & soft tissuethe forty-year plateau · MAP and the honest map
gate ✓ 13 props Bone & soft tissuethe fusion-defined bone cancer · every-two-weeks won its trial
gate ✓ 13 props Lung & thoraxthe exposure-made cancer · the IO-doublet rewrite
gate ✓ 13 props GIthe slow cancer with a clock of its own · grade routes everything
gate ✓ 13 props GIthe functional-syndrome family · where sunitinib lives
gate ✓ 13 props Cross-cuttingthe diagnosis that is a process · tissue-of-origin meets the panel era
gate ✓ 13 props Lung & thoraxthe two-disease mediastinum · the same drug, two verdicts
gate ✓ 12 props Head, neck & endocrinethe hormone-first gland · mitotane and the metanephrine rule
gate ✓ 13 props GIfirst bottom-up run (Pardha)
gate ✓ 14 props| trainer | properties | trials each | failures | source |
|---|---|---|---|---|
| gbm-idh-wildtype | 10 | 300 | 0 | NCI ↗ |
| all-adult | 12 | 300 | 0 | NCI ↗ |
| all-pediatric | 12 | 300 | 0 | NCI ↗ |
| all-infant | 14 | 300 | 0 | NCI ↗ |
| aml | 10 | 300 | 0 | NCI ↗ |
| apl | 13 | 300 | 0 | NCI ↗ |
| cll | 12 | 300 | 0 | NCI ↗ |
| cml | 11 | 300 | 0 | NCI ↗ |
| hairy-cell | 11 | 300 | 0 | NCI ↗ |
| mds | 14 | 300 | 0 | NCI ↗ |
| mpn | 13 | 300 | 0 | NCI ↗ |
| cmml | 14 | 300 | 0 | NCI ↗ |
| myeloma | 13 | 300 | 0 | NCI ↗ |
| al-amyloidosis | 13 | 300 | 0 | NCI ↗ |
| hodgkin | 11 | 300 | 0 | NCI ↗ |
| nlpbl | 14 | 300 | 0 | NCI ↗ |
| dlbcl | 14 | 300 | 0 | NCI ↗ |
| hgbl | 12 | 300 | 0 | NCI ↗ |
| pmbcl | 14 | 300 | 0 | NCI ↗ |
| follicular | 14 | 300 | 0 | NCI ↗ |
| pcfcl | 12 | 300 | 0 | NCI ↗ |
| cns-lymphoma | 12 | 300 | 0 | NCI ↗ |
| breast-early | 13 | 300 | 0 | NCI ↗ |
| inflammatory-breast | 12 | 300 | 0 | NCI ↗ |
| breast-metastatic | 12 | 300 | 0 | NCI ↗ |
| dcis | 10 | 300 | 0 | NCI ↗ |
| nsclc | 12 | 300 | 0 | NCI ↗ |
| sclc | 11 | 300 | 0 | NCI ↗ |
| colorectal | 12 | 300 | 0 | NCI ↗ |
| pancreatic | 12 | 300 | 0 | NCI ↗ |
| prostate | 13 | 300 | 0 | NCI ↗ |
| bladder | 13 | 300 | 0 | NCI ↗ |
| kidney-rcc | 13 | 300 | 0 | NCI ↗ |
| melanoma | 13 | 300 | 0 | NCI ↗ |
| skin-bcc | 12 | 300 | 0 | NCI ↗ |
| skin-scc | 14 | 300 | 0 | NCI ↗ |
| merkel | 14 | 300 | 0 | NCI ↗ |
| ovarian | 13 | 300 | 0 | NCI ↗ |
| endometrial | 13 | 300 | 0 | NCI ↗ |
| uterine-sarcoma | 12 | 300 | 0 | NCI ↗ |
| cervical | 13 | 300 | 0 | NCI ↗ |
| head-neck | 14 | 300 | 0 | NCI ↗ |
| thyroid | 13 | 300 | 0 | NCI ↗ |
| esophageal | 15 | 300 | 0 | NCI ↗ |
| gastric | 15 | 300 | 0 | NCI ↗ |
| hcc | 14 | 300 | 0 | NCI ↗ |
| biliary | 13 | 300 | 0 | NCI ↗ |
| anal | 14 | 300 | 0 | NCI ↗ |
| appendiceal | 12 | 300 | 0 | NCI ↗ |
| testicular | 13 | 300 | 0 | NCI ↗ |
| sts | 12 | 300 | 0 | NCI ↗ |
| gist | 12 | 300 | 0 | NCI ↗ |
| bone-osteo | 13 | 300 | 0 | NCI ↗ |
| bone-ewing | 13 | 300 | 0 | NCI ↗ |
| mesothelioma | 13 | 300 | 0 | NCI ↗ |
| gi-net | 13 | 300 | 0 | NCI ↗ |
| pnet | 13 | 300 | 0 | NCI ↗ |
| cup | 13 | 300 | 0 | NCI ↗ |
| thymoma | 12 | 300 | 0 | NCI ↗ |
| adrenal | 13 | 300 | 0 | NCI ↗ |
| small-intestine | 14 | 300 | 0 | NCI ↗ |
1,480 graded references resolve to primary sources — PubMed, ClinicalTrials.gov, FDA. Verbatim quotes are marked verbatim; secondhand claims say so; nothing is silently rounded up.
776 behavioral properties run 300 seeded Monte-Carlo trials each — 232,800 checks with 0 failures — plus golden-vector parity between the test suite and the app engine. The gate blocks release; CI enforces it.
Every spec carries review dates and a weekly refresh cycle. Trial-door statuses are verified against the registry firsthand and stamped. When evidence reverses, the reversal is kept as a teaching case — never silently deleted.
630 constraints — negative trials, harm signals, contested rituals, look-alike traps — print in the trainers exactly as written and are never relaxed.
Look-alike diagnoses reroute live to the right trainer — double-expressor to DLBCL, double-hit back again; the borders between entities are taught, not blurred.
No PHI anywhere. 677 scenarios and 677 quizzes are generated from the same spec that builds each app, so the teaching cases and the engine can never drift apart. Not medical advice.
How to use it: pick a cancer type above, set the synthetic patient’s findings (diagnosis confirmation, fitness, biomarkers), and watch the decision landscape re-rank live — with gates that refuse to rank until the workup earns it, outcome numbers tied to their trials, co-intervention and care-delivery layers, and quiz decks that interrogate the reasoning. Built for clinicians in training, tumor-board rehearsal, and patient-conversation prep.